• R-Biopharm AG
  • Contact
  • Media
  • Online Seminars
  • Events
Languages
  • Nederlands
  • Italiano
  • Français
  • Deutsch
  • Español
  • English
Subscribe
  • Start
  • Diagnostics
    • Allergology
    • Autoimmunity
    • Bacteriology
    • Gastroenterology
    • Human genetics
    • Mycology
    • Parasitology
    • Syndromic Testing
    • Tuberculosis
    • Virology
  • Indication
    • Allergies
    • Dermatophyte Infections
    • Gastrointestinal infections
    • Hospital aquired infections and drug resistance
    • Respiratory infections
    • Sexually transmitted infections
    • Therapeutic drug monitoring
    • Vector-borne infections
  • Technologies
    • Array
    • Immunoblot
    • ELISA
    • Real-time PCR
    • Rapid tests
    • Quality Assessment Products
    • MT-PCR
  • Systems
  • Product Finder
  • News
  • Shop
A Division of the R-Biopharm Group
  • Start
  • Diagnostics
    • Allergology
    • Autoimmunity
    • Bacteriology
    • Gastroenterology
    • Human genetics
    • Mycology
    • Parasitology
    • Syndromic Testing
    • Tuberculosis
    • Virology
  • Indication
    • Allergies
    • Dermatophyte Infections
    • Gastrointestinal infections
    • Hospital aquired infections and drug resistance
    • Respiratory infections
    • Sexually transmitted infections
    • Therapeutic drug monitoring
    • Vector-borne infections
  • Technologies
    • Array
    • Immunoblot
    • ELISA
    • Real-time PCR
    • Rapid tests
    • Quality Assessment Products
    • MT-PCR
  • Systems
  • Product Finder
  • News
  • Shop

Hospital aquired infections

Home » Indication » Hospital aquired infections
In the hospital, there is a dangerous visitor: What are the most recent research on Clostridium difficile?

In the hospital, there is a dangerous visitor: What are the most recent research on Clostridium difficile?

The bacteria Clostridium difficile colonizes every human intestine, although it may be harmful for those with compromised immune systems. It is becoming increasingly prevalent in hospitals. What [...]

READ MORE
Clostridium difficile: 10 tips for prevention

Clostridium difficile: 10 tips for prevention

The intestinal bacterium Clostridium difficile is one of the most common causes of nosocomial infections. Patients whose intestinal flora is disrupted due to the use of antibiotics are [...]

READ MORE
Clostridium difficile: Detect infections with certainty

Clostridium difficile: Detect infections with certainty

Clostridium difficile is one of the most frequent pathogens in nosocomial infections – but in spite of this many people have never heard of it. Since November is officially “Clostridium [...]

READ MORE
More efficient and flexible: RIDA®GENE real-time PCR kits in the new format

More efficient and flexible: RIDA®GENE real-time PCR kits in the new format

The new generation of the RIDA®GENE multiplex real-time PCR kits offers a number of improvements—and makes molecular laboratory diagnostics even more efficient and flexible.

READ MORE
Legionella and mycoplasma pneumoniae: New RIDA®GENE products for detection of atypical CAP bacteria

Legionella and mycoplasma pneumoniae: New RIDA®GENE products for detection of atypical CAP bacteria

Community-acquired pneumonia (CAP) is the most common fatal infectious disease in western countries. Bacteria are the most common pathogens causing CAP, where one differentiates between typical [...]

READ MORE

Clinical Diagnostics

A division of R-Biopharm AG
Subscribe to our newsletter
Company information
  • R-Biopharm AG
  • An der Neuen BergstraĂźe 17
    64297 Darmstadt, Germany
  • +49 (0) 61 51 - 81 02-0
  • +49 (0) 61 51 - 81 02-40
  • info@r-biopharm.de
  • www.r-biopharm.com
Copyright All Rights Reserved ©
  • Imprint
  • Privacy policy
  • GTCs
  • GTCs (Purchase)

Start typing and press Enter to search